THE global leader in  blood management solutions for our customers

2014 Press Releases

Keyword Search
 
2014 | 2013 | 2012 | 2011 | 2010
DateTitle 
Aug. 22, 2014Haemonetics to Present at Morgan Stanley's Global Healthcare Conference
BRAINTREE, Mass., Aug. 22, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at Morgan Stanley's Global Healthcare Conference in New York on September 8th, 2014 at 8:45am Eastern time.  The public may access Mr. Concannon's presentation live via webcast at: http://cc.talkpoint.com/morg007/090814a_ac/?entity=95_Q4T6LED About Haemonetics Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providi... 
Printer Friendly Version
Jul. 30, 2014Haemonetics Reports 1st Quarter Fiscal 2015 Revenue of $224 Million and Adjusted EPS of $0.38, Affirms Full Fiscal Year Guidance
BRAINTREE, Mass., July 30, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today reported first quarter fiscal 2015 revenue of $224.5 million, up 2%.  In constant currency, revenue growth was also 2% in the quarter.  The Company reported a GAAP net loss of $3.6 million and a GAAP net loss per share of $0.07 in the quarter.  Exclusive of transformation, restructuring and deal amortization expenses detailed below, adjusted net income was $19.7 million and adjusted earnings per share we... 
Printer Friendly Version
Jul. 23, 2014Charles J. Dockendorff Joins Haemonetics Board of Directors
BRAINTREE, Mass., July 23, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Charles J. Dockendorff was elected to the Board of Directors at the Company's Annual Meeting of Stockholders today.  Mr. Dockendorff, age 59, is Executive Vice President and Chief Financial Officer with Covidien PLC, a position he has held since 1995.  He is responsible for Covidien's financial management activities including corporate accounting, tax, treasury, financial planning, investor relatio... 
Printer Friendly Version
Jun. 30, 2014Haemonetics Sets Date for First Quarter Fiscal Year 2015 Earnings Release: July 30, 2014
BRAINTREE, Mass., June 30, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) will announce its earnings for the first quarter of its fiscal year 2015 on Wednesday, July 30, 2014 in a pre-market press release.  The Company will host a webcast to discuss and answer questions about the press release at 8:00 am eastern on July 30, 2014. Webcast Link: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=5163769 Webcast replay will be available from July 3... 
Printer Friendly Version
May. 28, 2014Haemonetics to Present at the William Blair & Company Growth Stock Conference
BRAINTREE, Mass., May 28, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Chris Lindop, CFO & EVP, Business Development, will present at the William Blair & Company Growth Stock Conference in Chicago on June 11th, 2014 at 2:20pm Eastern time.  The public may access Mr. Lindop's presentation live via webcast at: http://wsw.com/webcast/blair48/hae About Haemonetics Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovati... 
Printer Friendly Version
May. 27, 2014Haemonetics to Present at The Goldman Sachs 35th Annual Global Healthcare Conference
BRAINTREE, Mass., May 27, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at The Goldman Sachs 35th Annual Global Healthcare Conference in California on June 12th, 2014 at 12:20pm Eastern time.  The public may access Mr. Concannon's presentation live via webcast at: http://cc.talkpoint.com/gold006/061014a_an/?entity=44_HWB0858  About Haemonetics Haemonetics (NYSE: HAE) is a global healthcare company dedic... 
Printer Friendly Version
May. 23, 2014Haemonetics to Present at The Jefferies 2014 Global Healthcare Conference
BRAINTREE, Mass., May 23, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Chris Lindop, CFO & EVP-Business Development, will present at The Jefferies 2014 Global Healthcare Conference in New York on June 4th, 2014 at 2:30pm Eastern time.  The public may access Mr. Lindop's presentation live via webcast at: http://wsw.com/webcast/jeff82/hae About Haemonetics Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood man... 
Printer Friendly Version
Apr. 30, 2014Kent Davies Joins Haemonetics as President, Global Markets
BRAINTREE, Mass., April 30, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced today that Kent J. Davies will join the Company effective May 12, 2014 as President, Global Markets.  Mr. Davies will join Haemonetics as a member of the Executive Council and Operating Committee, assuming responsibility for worldwide oversight of all of the Company's commercial operations, except the Global Plasma business.  In this role, Mr. Davies will have responsibility for business elements repres... 
Printer Friendly Version
Apr. 28, 2014Haemonetics Authorizes $100 Million Share Repurchase Program
BRAINTREE, Mass., April 28, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that its Board of Directors has approved the repurchase of up to $100 million of shares, consistent with its loan covenants.  In approving the repurchase, the Board acknowledged the company's strong cash flow and $192 million cash balance.  Haemonetics President and CEO stated: "Our Board of Directors expressed confidence in the Company's strategic plan and cash generating ability.  We have the res... 
Printer Friendly Version
Apr. 28, 2014Haemonetics Reports 4th Quarter Fiscal 2014 Revenue of $241 Million and Adjusted EPS of $0.46; Full Year Revenue of $939 Million, Up 5% and Adjusted EPS of $2.19, Up 10%
BRAINTREE, Mass., April 28, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today reported revenue for the fourth quarter fiscal 2014 of $241.1 million, down 4%.  Excluding currency impact, revenue was down 2% in the quarter.1  The Company's base revenue, exclusive of the recently acquired whole blood business, increased 2% on a constant currency basis in the quarter.  Fourth quarter GAAP net income was $10.2 million and earnings per share were $0.19.  Adjusted net income, exclusive... 
Printer Friendly Version
Apr. 01, 2014Haemonetics Sets Date for Fourth Quarter and Full Fiscal Year 2014 Earnings Release: April 28, 2014
BRAINTREE, Mass., April 1, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) will announce its earnings for the fourth quarter and full fiscal year 2014 and will provide guidance for fiscal year 2015 on April 28, 2014 in a pre-market press release.  The Company will hold a webcast to discuss and answer questions about the press release at 8:00 am (EDT) on April 28, 2014. Webcast Link: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=5122981 Webca... 
Printer Friendly Version
Mar. 24, 2014Haemonetics Provides Update on U.S. Whole Blood Supply Tender
BRAINTREE, Mass., March 24, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that it was not selected to supply The American Red Cross with certain whole blood collection components.  The Company was informed that a competitor was chosen to supply these products on an exclusive basis.      Haemonetics provided the following information regarding its whole blood collection kit business with The American Red Cross: Haemonetics currently supplies 1.8 million in-line ... 
Printer Friendly Version
Feb. 13, 2014Haemonetics to Present at the Raymond James 35th Annual Institutional Investors Conference
BRAINTREE, Mass., Feb. 13, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at the Raymond James 35th Annual Institutional Investors Conference in Orlando, FL on Tuesday, March 4, 2014 at 8:05 am Eastern time.  The public may access Mr. Concannon's presentation live via webcast at http://wsw.com/webcast/rj89/HAE The webcast will be archived and available for approximately 90 days.  Haemonetics (NYSE: HAE) is... 
Printer Friendly Version
Feb. 05, 2014Haemonetics Sets Date for Investor/Analyst Meeting - May 20, 2014
BRAINTREE, Mass., Feb. 5, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that it will host its annual investor and analyst meeting on Tuesday, May 20th from 10:00 am to 2:00 pm at The State Room, 60 State Street in Boston, Massachusetts. (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The agenda for the meeting includes updates on the following: Whole Blood Strategy / U.S. Tenders / International Expansion Plans Hospital Based Blood Manageme... 
Printer Friendly Version
Jan. 27, 2014Haemonetics Reports 3rd Quarter Fiscal 2014 Revenue of $242 Million and $0.61 Adjusted EPS; Extends Multi-Year Agreements With Key Plasma Customers
BRAINTREE, Mass., Jan. 27, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today reported third quarter fiscal 2014 net revenue of $242.1 million, down 2%. The Company's base revenue, exclusive of the recently-acquired whole blood business, increased 1% in the third quarter and increased 4% on a constant currency basis.  Excluding currency impact, net revenue was flat in the quarter.(1)  (Logo:  http://photos.prnewswire.com/prnh/20120206/NE47232LOGO) GAAP net income was $16.3 mi... 
Printer Friendly Version
Jan. 12, 2014Haemonetics Announces Signing of Supply Agreement with HemeXcel at J.P. Morgan Health Care Conference
BRAINTREE, Mass., Jan. 12, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that it has entered into a multi-year agreement to supply the HemeXcel Purchasing Alliance LLC with certain whole blood collection components on an exclusive basis during calendar years 2014-2016.  The announcement was made in conjunction with the 32nd Annual J.P. Morgan Health Care Conference in San Francisco.    (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) "We are very p... 
Printer Friendly Version
Jan. 03, 2014Haemonetics Business Update at J.P. Morgan Health Care Conference Will Include Status of U.S. Whole Blood Tenders
BRAINTREE, Mass., Jan. 3, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that it will provide a general business update, including an update with respect to ongoing U.S. whole blood tenders, in conjunction with the 32nd Annual J.P. Morgan Health Care Conference in San Francisco.  Brian Concannon, President and CEO of Haemonetics, will comment on these tenders as part of a live webcast presentation at 10:00AM Pacific / 1:00PM Eastern time on Wednesday, January 15.  As pr... 
Printer Friendly Version
Jan. 02, 2014Haemonetics to Present at the 32nd Annual J.P. Morgan Health Care Conference
BRAINTREE, Mass., Jan. 2, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at the 32nd Annual J.P. Morgan Health Care Conference in San Francisco on Wednesday, January 15, 2014 at 10:00 am Pacific time / 1:00 pm Eastern time.  (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO )   The public may access Mr. Concannon's presentation live via webcast at http://jpmorgan.metameetings.com/confbook/healthcar... 
Printer Friendly Version